Sequence of neurofibrillary changes in aging and Alzheimer's disease: A confocal study with phospho-tau antibody, AD2

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2001-08-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2001-3409PMID 12214046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease.

  2001cited by this paper
• The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old

  2000cited by this paper
• Tau Phosphorylation at Serine 396 and Serine 404 by Human Recombinant Tau Protein Kinase II Inhibits Tau's Ability to Promote Microtubule Assembly*

  2000cited by this paper
• Progression of Alzheimer-Related Neuritic Plaque Pathology in the Entorhinal Region, Perirhinal Cortex and Hippocampal Formation

  1999cited by this paper
• Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease

  1999cited by this paper
• Production of paired helical filament, tau‐like proteins by PC12 cells: A model of neurofibrillary degeneration

  1998cited by this paper
• Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

  1997influential reference
• Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

  1997cited by this paper
• Modeling the relation between neurofibrillary tangles and intellectual status.

  1997cited by this paper
• Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer’s disease

  1996influential reference
• Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments.

  1996influential reference
• AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease.

  1996cited by this paper
• Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease

  1996cited by this paper
• Hyperphosphorylation of tau in PHF.

  1995cited by this paper
• Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*)

  1995cited by this paper
• Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease.

  1995cited by this paper
• Correlations of synaptic and pathological markers with cognition of the elderly.

  1995cited by this paper
• Immunohistochemical Staging of Neurofibrillary Degeneration in Alzheimer's Disease

  1994cited by this paper
• Posttranslational modifications of tau in paired helical filaments.

  1994cited by this paper
• Microtubule-associated proteins tau and amyloid P component in Alzheimer's disease.

  1993cited by this paper
• Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease.

  1993cited by this paper
• Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques.

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

  1992cited by this paper
• The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

  1991cited by this paper
• Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.

  1991cited by this paper
• Design and synthesis of a potential affinity/cleaving reagent for beta-pleated sheet protein structures

  1991cited by this paper
• Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.

  1990cited by this paper
• Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.

  1989influential reference
• Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments

  1986cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper

• Membrane Association of Intrinsically Disordered Proteins.

  2025cites this paper
• Vulnerability of the entorhinal cortex II to neurodegeneration in Alzheimer’s disease

  2025cites this paper
• Support for the Amyloid Cascade Hypothesis in Guiding Further Avenues of Treatment in Alzheimer's Disease

  2023cites this paper
• SUMO2 Protects Against Tau-induced Synaptic and Cognitive Dysfunction

  2022cites this paper
• Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration

  2021cites this paper
• PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease

  2020cites this paper
• National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in México

  2020cites this paper
• Tau and tauopathies.

  2016cites this paper
• 14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells

  2016cites this paper
• Assembly and Disassembly of Protein Aggregates

  2015cites this paper
• The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease

  2015cites this paper
• Expediting the Discovery and Potential Translation of Theranostic Agents for Alzheimer's Disease

  2015cites this paper
• Phosphorylation of tau protein at sites Ser396–404 is one of the earliest events in Alzheimer's disease and Down syndrome

  2014cites this paper
• Tau Monoclonal Antibody Generation Based on Humanized Yeast Models

  2014cites this paper
• Einzelmolekülbasierte Analyse des Aggregationsverhaltens von Tau-Protein und sein Verhalten in der Koaggregation mit Alpha-Synuklein

  2014influential citation
• Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies.

  2013cites this paper
• Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles.

  2013cites this paper
• Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein.

  2012cites this paper
• Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated by N-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation*

  2012cites this paper
• Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases

  2012cites this paper
• The role of the lipid bilayer in tau aggregation.

  2010cites this paper
• Gene-environment interplay in neurogenesis and neurodegeneration

  2009cites this paper
• Stages of Pathological Tau-Protein Processing in Alzheimer’s Disease: From Soluble Aggregations to Polymerization into Insoluble Tau-PHFs

  2009cites this paper
• Tau aggregation: role in neurodegeneration and inhibition with small molecules

  2009cites this paper
• Structure-activity relationship of cyanine tau aggregation inhibitors.

  2009cites this paper
• Nucleation-dependent Tau Filament Formation

  2008cites this paper
• Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer’s disease in tissue imprints

  2008cites this paper
• The Last Tangle of Tau

  2008cites this paper
• Cerebral Cortical Arteriolar Angiopathy, Vascular Beta-Amyloid, Smooth Muscle Actin, Braak Stage, and APOE Genotype

  2008cites this paper
• Conditionally inducible tau mice – designing a better mouse model of neurodegenerative diseases

  2008cites this paper
• Is Tau Aggregation Toxic or Protective?

  2008cites this paper
• Earliest Stages of Tau Conformational Changes are Related to the Appearance of a Sequence of Specific Phospho-Dependent Tau Epitopes in Alzheimer's Disease

  2007cites this paper
• The role of tau phosphorylation and cleavage in neuronal cell death.

  2007cites this paper
• Cognitive decline and human (Homo sapiens) aging: an investigation using a comparative neuropsychological approach.

  2007cites this paper
• Activation of Glycogen Synthase Kinase 3β Promotes the Intermolecular Association of Tau

  2007cites this paper
• Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

  2007cites this paper
• Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions

  2006influential citation
• Pin1 protein associates with neuronal lipofuscin: potential consequences in age-related neurodegeneration.

  2006cites this paper
• Triggers and enhancers of tau aggregation : implication for AD pathogenesis.

  2006cites this paper
• C‐terminal truncation modulates both nucleation and extension phases of τ fibrillization

  2006cites this paper
• Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease

  2005cites this paper
• Pathways of tau fibrillization.

  2005cites this paper
• Evaluating triggers and enhancers of tau fibrillization

  2005influential citation
• Casein kinase 1 isoforms in degenerative disorders.

  2004influential citation
• Electron microscopy as a quantitative method for investigating tau fibrillization.

  2004cites this paper
• A static laser light scattering assay for surfactant-induced tau fibrillization.

  2004cites this paper
• Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules*

  2004cites this paper